In the long term, findings on what controls the speed of cellular evolution might lead to targeted therapies that delay genetic instability in specific cancer types and prolong human healthy lifespan.
Physicians need to create a visible presence online to dispel the common misbelief that clinical trials are only appropriate for patients who are dying, or for those left without any other treatment options.
—Miriam A. Knoll, an oncologist at the John Theurer Cancer Center at Hackensack University Medical Center in New Jersey, writing in Forbes about using social media to educate the public on trials of new cancer drugs (February 15)
ACROSS 1. What hares and rheas are... |
jonny hawkins
Interested in reading more?
Become a Member of
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!